Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom. Show more
The Innovation Centre, Abingdon, OX14 4RY, United Kingdom
Market Cap
10.34M
52 Wk Range
$0.00 - $0.36
Previous Close
$0.04
Open
$0.05
Volume
232,683
Day Range
$0.04 - $0.05
Enterprise Value
32.16M
Cash
26.06M
Avg Qtr Burn
-34.78M
Insider Ownership
0.63%
Institutional Own.
0.00%
Qtr Updated
06/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|